ConductScience.org, home

Paper404363

Inactivated Venezuelan equine encephalomyelitis virus vaccine complexed with specific antibody: enhanced primary immune response and altered pattern of antibody class elicited.

Houston WE and 3 others. J Infect Dis, 1977. Cited by 24 papers, by iCite.

Cite this record

ConductScience Library. Inactivated Venezuelan equine encephalomyelitis virus vaccine complexed with specific antibody: enhanced primary immune response and altered pattern of antibody class elicited. Papers, record 404363. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/404363

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Inactivated Venezuelan equine encephalomyelitis virus vaccine complexed with specific antibody: enhanced primary immune response and altered pattern of antibody class elicited.
PubMed
Journal
J Infect Dis
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
24
iCite
Relative citation ratio, by iCite
0.46
iCite
Revised in PubMed
2019-05-09
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Houston WEW E
2Kremer RJR J
3Crabbs CLC L
4Spertzel ROR O

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibody FormationMajor topic
Encephalitis Virus, Eastern EquineMajor topic
Encephalitis VirusesMajor topic
Immunoglobulin GMajor topic
Animals
Antigen-Antibody Complex
Female
Haplorhini
Immunity
Immunity, Maternally-Acquired
Immunization, Secondary
Macaca
Male
Mice
Semliki forest virus

Source PubMed

Download CSV of topics

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.

PMIDTitleJournalYearIn PapersSource
34853815Increasing Efficacy of Enveloped Whole-Virus Vaccines by In situ Immune-Complexing with the Natural Anti-Gal Antibody.Med Res Arch2021https://conductscience.org/library/papers/34853815PubMed
32907757Amplifying immunogenicity of prospective Covid-19 vaccines by glycoengineering the coronavirus glycan-shield to present α-gal epitopes.Vaccine2020https://conductscience.org/library/papers/32907757PubMed
32580274Human Natural Antibodies to Mammalian Carbohydrate Antigens as Unsung Heroes Protecting against Past, Present, and Future Viral Infections.Antibodies (Basel)2020https://conductscience.org/library/papers/32580274PubMed
26497515Fcγ receptor pathways during active and passive immunization.Immunol Rev2015https://conductscience.org/library/papers/26497515PubMed
26018152Immunization with Immune Complexes Modulates the Fine Specificity of Antibody Responses to a Flavivirus Antigen.J Virol2015https://conductscience.org/library/papers/26018152PubMed
23836278Multi-therapeutic potential of autoantibodies induced by immune complexes trapped on follicular dendritic cells.Hum Vaccin Immunother2013https://conductscience.org/library/papers/23836278PubMed
23637771Immune-complex mimics as a molecular platform for adjuvant-free vaccine delivery.PLoS One2013https://conductscience.org/library/papers/23637771PubMed
17609270Immunogenicity of influenza virus vaccine is increased by anti-gal-mediated targeting to antigen-presenting cells.J Virol2007https://conductscience.org/library/papers/17609270PubMed
16809300Increased immunogenicity of human immunodeficiency virus gp120 engineered to express Galalpha1-3Galbeta1-4GlcNAc-R epitopes.J Virol2006https://conductscience.org/library/papers/16809300PubMed
15664904Antibody-mediated immunomodulation: a strategy to improve host responses against microbial antigens.Infect Immun2005https://conductscience.org/library/papers/15664904PubMed
15205919Autologous tumor vaccines processed to express alpha-gal epitopes: a practical approach to immunotherapy in cancer.Cancer Immunol Immunother2004https://conductscience.org/library/papers/15205919PubMed
3877176Amplification of rabies virus-induced stimulation of human T-cell lines and clones by antigen-specific antibodies.J Virol1985https://conductscience.org/library/papers/3877176PubMed
226031Colostral immunity in piglets from sows vaccinated with inactivated Aujeszky disease virus vaccine.Arch Virol1979https://conductscience.org/library/papers/226031PubMed
110688
Adjuvant effects of low doses of a nuclease-resistant derivative of polyinosinic acid . polycytidylic acid on antibody responses of monkeys to inactivated Venezuelan equine encephalomyelitis virus vaccine.
Infect Immun1979https://conductscience.org/library/papers/110688PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/404363

GET https://conductscience.org/api/papers/v1/404363/authors